inCytes™ is the physician-facing technical foundation of Circles. It complements the patient-facing platform, Benchmarc™. Combined RegenMed’s processes, these platforms enable the cost-efficient and minimally burdensome generation of clinical, scientific, and financial value from real-world data.
inCytes™ is competitive with EDC, ePRO, CRO and other more expensive data collection platforms. It is protected by U.S. patent number 11720567, Method and System For Processing Large Amounts of Real-World Evidence.
inCytes™ is HIPAA, GDPR and Part 11 compliant. Its permissions settings give Circle Members full control over their individual data sets, while preserving the ability to share aggregated datasets.
Circles are designed from the ground up to provide busy practitioners with an excellent user experience. The administrative burden of data collection is eliminated, allowing physicians to focus on patient care, practice-specific study parameters, analysis of correlations, and publishing/influence.
FLEXIBLE AND SCALABLE
The inherent flexibility and scalability of inCytes™ accommodate a small, private Circle by a single clinician, or an international, multi-center clinical trial. inCytes™ enables seamless Circle participation by any number of clinicians within and across institutional and national boundaries. Other sources of relevant real-world data -- such as physicians assistants, laboratory technicians, and referring clinicians – can also be enrolled as Circle Members.
DATA EXPORT, IMPORT AND INTEGRATION
Unlike other data platforms, inCytes™ allows 24/7 access to all data and report generation, as well as raw data exports. It also includes a public API, a powerful data migration engine and other processes for data hygiene, import and export.